Board of Directors
Erich Hunziker
Since July 2019 Dr. Erich Hunziker is the Chairman of NovImmune. He is also Chairman of the Board of Directors of BB Biotech AG. He previously served as CFO of Roche from 2001 to 2010. From 1983 to 2001 he held various executive positions at Corange, Boehringer Mannheim and at Diethelm-Keller-Group (DKSH), where he ultimately served as CEO.
In 2013 he was the seed investor to support EngMab AG, which successfully developed a BCMA-bispecific Antibody: EngMab was sold to Celgene in 2016.
Dr. Erich Hunziker is Chairman of Entsia International AG and a co-founder and a member of the Boards of the LamKap Bio group.
Dr. Erich Hunziker earned a Ph.D. in Industrial Engineering from the Swiss Federal Institute of Technology in Zurich.
